• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection

tetano

Editor, Senior Moderator
Front Immunol


. 2022 May 31;13:901217.
doi: 10.3389/fimmu.2022.901217. eCollection 2022.
Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection


Lindsay Wieczorek[SUP] 1 2 [/SUP], Michelle Zemil[SUP] 1 2 [/SUP], Mélanie Merbah[SUP] 1 2 [/SUP], Vincent Dussupt[SUP] 1 2 [/SUP], Erin Kavusak[SUP] 1 2 [/SUP], Sebastian Molnar[SUP] 1 2 [/SUP], Jonah Heller[SUP] 1 2 [/SUP], Bradley Beckman[SUP] 1 2 [/SUP], Suzanne Wollen-Roberts[SUP] 1 2 [/SUP], Kristina K Peachman[SUP] 3 [/SUP], Janice M Darden[SUP] 2 3 [/SUP], Shelly Krebs[SUP] 1 2 [/SUP], Morgane Rolland[SUP] 1 2 [/SUP], Sheila A Peel[SUP] 3 [/SUP], Victoria R Polonis[SUP] 1 [/SUP]



Affiliations

Abstract

Fc-mediated virus entry has been observed for many viruses, but the characterization of this activity in convalescent plasma against SARS-CoV-2 Variants of Concern (VOC) is undefined. In this study, we evaluated Fc-mediated viral entry (FVE) on FcγRIIa-expressing HEK293 cells in the presence of SARS-CoV-2 convalescent plasma and compared it with SARS-CoV-2 pseudovirus neutralization using ACE2-expressing HEK293 cells. The plasma were collected early in the pandemic from 39 individuals. We observed both neutralization and FVE against the infecting Washington SARS-CoV-2 strain for 31% of plasmas, neutralization, but not FVE for 61% of plasmas, and no neutralization or FVE for 8% of plasmas. Neutralization titer correlated significantly with the plasma dilution at which maximum FVE was observed, indicating Fc-mediated uptake peaked as neutralization potency waned. While total Spike-specific plasma IgG levels were similar between plasma that mediated FVE and those that did not, Spike-specific plasma IgM levels were significantly higher in plasma that did not mediate FVE. Plasma neutralization titers against the Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1) and Delta (B.1.617.2) VOC were significantly lower than titers against the Washington strain, while plasma FVE activity against the VOC was either higher or similar. This is the first report to demonstrate a functional shift in convalescent plasma antibodies from neutralizing and FVE-mediating against the earlier Washington strain, to an activity mediating only FVE and no neutralization activity against the emerging VOC, specifically the Beta (B.1.351) and Gamma (P.1) VOC. It will be important to determine the in vivo relevance of these findings.

Keywords: Fc-mediated virus entry; SARS-CoV-2; antibody dependent enhancement; coronavirus – COVID-19; neutralization; pseudovirus; spike (S) protein; variant of concern.
 
Back
Top Bottom